Salient Midstream & MLP Fund (SMM) Income Statement & Balance Sheet → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free SMM Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share FinancialsStock Analysis Salient Midstream & MLP Fund Income Statement, Balance Sheet and Cash Flow Statement→ Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) Related Companies: Aberdeen Total Dynamic Dividend Fund Financials BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Financials Cohen & Steers Limited Duration Preferred and Income Fund Financials RiverNorth Capital and Income Fund Financials XAI Octagon Floating Rate & Alternative Income Trust Financials Nuveen Multi-Asset Income Fund Financials Virtus Artificial Intelligence & Technology Opportunities Fund Financials Receive SMM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Salient Midstream & MLP Fund and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:SMM) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Salient Midstream & MLP Fund Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.